Skip to product information
1 of 1

Biotin Mouse Anti-Human CD172a (SIRPα) Antibody (S-4039)

Biotin Mouse Anti-Human CD172a (SIRPα) Antibody (S-4039)

Catalog Number: S0B8543 Application: FCM Reactivity: Human Conjugation: Biotin Brand: Starter
Price:
Regular price $45 USD
Regular price Sale price $45 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen CD172a (SIRPα)
Synonyms Tyrosine-protein phosphatase non-receptor type substrate 1; SHP substrate 1; SHPS-1; Brain Ig-like molecule with tyrosine-based activation motifs (Bit); CD172 antigen-like family member A; Inhibitory receptor SHPS-1; Macrophage fusion receptor; MyD-1 antigen; CD172a; BIT; MFR; MYD1; PTPNS1; SHPS1; SIRP; SIRPA
Location Membrane
Accession P78324
Clone Number S-4039
Antibody Type Mouse mAb
Isotype IgG2a,k
Application FCM
Reactivity Hu
Positive Sample human peripheral blood leukocytes
Purification Protein A
Concentration 0.2 mg/ml
Conjugation Biotin
Physical Appearance Liquid
Storage Buffer

PBS pH7.4, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 1.25μl per million cells in 100μl volume Hu

Background

Signal-regulatory protein alpha (SIRPα, also known as CD172a or SHPS-1) is a type I transmembrane glycoprotein of the immunoglobulin superfamily, prominently expressed on myeloid cells, neurons, and stem cells, that functions as an inhibitory receptor by binding to the broadly expressed ligand CD47 (the “don’t eat me” signal) to negatively regulate innate immune effector functions such as macrophage phagocytosis of healthy host cells; upon CD47 engagement, phosphorylation of its cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs) recruits phosphatases like SHP-1 and SHP-2, thereby blocking actin cytoskeleton remodeling required for phagocytic activity, while structural studies have revealed its extracellular region contains three Ig-like domains (one V-set and two C1-set) and the interaction surface resembles antigen-receptor binding; in cancer, tumor cells exploit this CD47-SIRPα axis as an innate immune checkpoint to evade phagocytosis, making SIRPα a promising therapeutic target, especially in combination with anti-PD-1/PD-L1 therapies .

Picture

FC

Flow cytometric analysis of Human CD172a (SIRPα) expression on human peripheral blood leukocytes. Human peripheral blood leukocytes were stained with SDT Biotin Mouse Anti- Human CD172a (SIRPα) antibody at 1.25 μl/test followed by Sav-iFluor 488. Total viable cells, as determined by Fixable Viability Dye 662 (S0D0016), were used for analysis. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.